Generalizability in Two Clinical Trials in Lyme Disease
Daniel Cameron of the International Lyme and Infectious Diseases Society contends that Klempner’s studies on long term Lyme treatment are flawed, due to limiting the selection of patients to those who experienced similar treatment failure in the past. Includes table.
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&artid=1626453&blobtype=pdf